"I still see a 3-4$ price"statements like these (based on what? a vision? intuition?) with no data or analysis to support them are baseless whimsical fantasy..cmon mate....seriouslyonto ignore u go
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%